Amide Technologies

📍 Cambridge, United States👥 15 employees💰 Last funded Jul 2025
Amide Technologies offers on-demand complex peptide manufacturing at unprecedented speed. Through its novel manufacturing platform developed at MIT, Amide is bridging the gap between traditional solid phase peptide synthesis and biological expression, empowering scientists on the cutting edge of peptide drug design.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Amide Technologies?
Amide Technologies has 1 investors on record on gritt.io.
When did Amide Technologies last raise funding?
The most recent investment in Amide Technologies recorded on gritt.io was in July 2025.
What industry is Amide Technologies in?
Amide Technologies operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Amide Technologies based?
Amide Technologies is headquartered in Cambridge, United States.